VRTX Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

$268.45  +9.86 (3.81%)
As of 05/23/2022 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/08/2001
Outstanding shares:  255,755,961
Average volume:  1,828,635
Market cap:   $65,332,860,237
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2931034

---

Valuation   (See tab for details)

---

PE ratio:   26.98
PB ratio:   6.06
PS ratio:   8.22
Return on equity:   22.47%
Net income %:   30.84%